Patents by Inventor Eva Marie PRINZ

Eva Marie PRINZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TTS-FORMULATION WITH THC
    Publication number: 20240130978
    Abstract: Disclosed is a transdermal therapeutic system comprising an active agent impermeable backing layer, at least one adhesive layer comprising at least 70% by weight of at least one polysiloxane polymer, at least one tetrahydrocannabinol (THC) and at least one solubilizer, and optionally a protective layer for removal before use, a method for its preparation and its use as a medicament.
    Type: Application
    Filed: February 17, 2022
    Publication date: April 25, 2024
    Inventors: Eva-Marie PRINZ, Marco EMGENBROICH, Birgit BRAUN, Peter BOHNENKÄMPER
  • TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING A SILICONE POLYMER
    Publication number: 20230241004
    Abstract: The present invention relates to a transdermal therapeutic system for the transdermal administration of guanfacine comprising a guanfacine-containing layer structure, said guanfacine-containing layer structure comprising: A) a backing layer; and B) a guanfacine-containing layer; wherein the transdermal therapeutic system comprises at least one silicone polymer.
    Type: Application
    Filed: January 11, 2023
    Publication date: August 3, 2023
    Applicants: LTS LOHMANN Therapie-Systeme AG, DDP Specialty Electronic Materials US 9, LLC
    Inventors: Marco EMGENBROICH, Eva-Marie PRINZ, Elke KLEIN, Heike KLUTH, Xavier THOMAS, Linda Sue NARTKER
  • Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymer
    Patent number: 11576874
    Abstract: The present invention relates to a transdermal therapeutic system for the transdermal administration of guanfacine comprising a guanfacine-containing layer structure, said guanfacine-containing layer structure comprising: A) a backing layer; and B) a guanfacine-containing layer; wherein the transdermal therapeutic system comprises at least one silicone polymer.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: February 14, 2023
    Assignees: LTS LOHMANN Therapie-Systeme AG, DDP Specialty Electronic Materials US 9, LLC
    Inventors: Marco Emgenbroich, Eva-Marie Prinz, Elke Klein, Heike Kluth, Xavier Thomas, Linda Sue Nartker
  • TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING AT LEAST ONE ADDITIVE
    Publication number: 20200397715
    Abstract: The present invention relates to a transdermal therapeutic system for the transdermal administration of guanfacine comprising a guanfacine-containing layer structure, said guanfacine-containing layer structure comprising: A) a backing layer; and B) a guanfacine-containing layer; wherein the transdermal therapeutic system comprises at least one polymer and at least additive.
    Type: Application
    Filed: October 11, 2018
    Publication date: December 24, 2020
    Inventors: Marco EMGENBROICH, Eva-Marie PRINZ, Elke KLEIN, Heike KLUTH, Xavier THOMAS, Linda Sue NARTKER
  • TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING A SILICONE ACRYLIC HYBRID POLYMER
    Publication number: 20200397714
    Abstract: The present invention relates to a transdermal therapeutic system for the transdermal administration of guanfacine comprising a guanfacine-containing layer structure, said guanfacine-containing layer structure comprising: A) a backing layer; and B) a guanfacine-containing layer; wherein the transdermal therapeutic system comprises at least one silicone acrylic hybrid polymer.
    Type: Application
    Filed: October 11, 2018
    Publication date: December 24, 2020
    Inventors: Marco EMGENBROICH, Eva-Marie PRINZ, Elke KLEIN, Heike KLUTH, Xavier THOMAS, Linda Sue NARTKER
  • TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING A SILICONE POLYMER
    Publication number: 20200315987
    Abstract: The present invention relates to a transdermal therapeutic system for the transdermal administration of guanfacine comprising a guanfacine-containing layer structure, said guanfacine-containing layer structure comprising: A) a backing layer; and B) a guanfacine-containing layer; wherein the transdermal therapeutic system comprises at least one silicone polymer.
    Type: Application
    Filed: October 11, 2018
    Publication date: October 8, 2020
    Inventors: Marco EMGENBROICH, Eva-Marie PRINZ, Elke KLEIN, Heike KLUTH, Xavier THOMAS, Linda Sue NARTKER
  • Melatonin-based formulations for parenteral administration
    Patent number: 9468626
    Abstract: Pharmaceutical formulations comprising nanoparticles of melatonin are useful for the treatment of neonatal brain injury.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: October 18, 2016
    Assignee: CHIESI FARMACEUTICI S.p.A.
    Inventors: Annamaria Soliani Raschini, Akif Emre Türeli, Eva Marie Prinz
  • MELATONIN-BASED FORMULATIONS FOR PARENTERAL ADMINISTRATION
    Publication number: 20150258064
    Abstract: Pharmaceutical formulations comprising nanoparticles of melatonin are useful for the treatment of neonatal brain injury.
    Type: Application
    Filed: March 10, 2015
    Publication date: September 17, 2015
    Applicant: CHIESI FARMACEUTICI S.p.A.
    Inventors: Annamaria Soliani RASCHINI, Akif Emre TÜRELI, Eva Marie PRINZ